| Serial Number | 86923538 |
| Word Mark | Z |
| Filing Date | Monday, February 29, 2016 |
| Status | 701 - SECTION 8 - ACCEPTED |
| Status Date | Thursday, October 5, 2023 |
| Registration Number | 5324651 |
| Registration Date | Tuesday, October 31, 2017 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 3, 2017 |
| Description of Mark | The mark consists of a orange colored shield with the letter "Z" included in the shield in white. |
| Indication of Colors claimed | The color(s) orange, and white is/are claimed as a feature of the mark. |
| Goods and Services | Bacteriological consultation and research; Bacteriological research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Compiling data for research purposes in the field of medical science and medical consultancy; Conducting clinical trials for others in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Development of pharmaceutical preparations and medicines; Diagnostic services in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Drug discovery services; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genotyping services for research or analysis purposes; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical and scientific research information in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research services in the field of cancer; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research and development; Scientific research consulting in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of oncology; Scientific study and research in the field(s) of rheumatoid arthritis; Scientific study and research in the field(s) of diabetes; Scientific study and research in the field(s) of metabolic disorders; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 3, 2016 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, June 22, 2015 |
| First Use In Commerce Date | Thursday, March 31, 2016 |
| Party Name | Zumutor Biologics Inc |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Zumutor Biologics Inc |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Woburn, MA 01801 |
| Party Name | Zumutor Biologics Inc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Woburn, MA 01801 |
| Event Date | Event Description |
| Thursday, October 5, 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| Thursday, October 5, 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| Thursday, October 5, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, May 26, 2023 | TEAS SECTION 8 RECEIVED |
| Monday, October 31, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, October 31, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, September 27, 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, September 26, 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, September 20, 2017 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, August 28, 2017 | USE AMENDMENT FILED |
| Thursday, September 14, 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, August 28, 2017 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, February 28, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 3, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 3, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 14, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 29, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, November 23, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, November 22, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 22, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 8, 2016 | ASSIGNED TO LIE |
| Friday, October 28, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 10, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 10, 2016 | NON-FINAL ACTION E-MAILED |
| Friday, June 10, 2016 | NON-FINAL ACTION WRITTEN |
| Friday, June 10, 2016 | ASSIGNED TO EXAMINER |
| Friday, March 4, 2016 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, March 3, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 3, 2016 | NEW APPLICATION ENTERED |